Multicenter Study

. 2024 Nov 15;22(1):535.

doi: 10.1186/s12916-024-03755-8.

Triglyceride-lowering therapies in hypertriglyceridemia-associated acute pancreatitis in China: a multicentre prospective cohort study

Jing Zhou^#^{1

2

3}, Zuozheng Wang^#⁴, Qinghong Liu^#⁵, Longxiang Cao^{1

2}, Enrique de-Madaria⁶, Gabriele Capurso⁷, Christian Stoppe⁸, Dong Wu⁹, Wei Huang¹⁰, Yingjie Chen^{11

12}, Siyao Liu¹³, Donghuang Hong¹⁴, Yun Sun¹⁵, Zhenguo Zeng¹⁶, Kaixiu Qin¹⁷, Haibin Ni¹⁸, Yi Sun¹⁹, Yue Long²⁰, Feng Guo²¹, Xiaofeng Liu²², Xisheng Zheng²³, Guoxiu Zhang²⁴, Xiangcheng Zhang²⁵, Kai Zhou²⁶, Yizhe Chen²⁷, Qinghai Jiao²⁸, Xinsen Zou²⁹, Xiang Luo³⁰, Gang Li¹, Bo Ye¹, Chao Li³¹, Lanting Wang¹, Shuai Li¹, John Windsor³², Yuxiu Liu^{1

2

33}, Zhihui Tong¹, Weiqin Li^{34

35

36}, Lu Ke^{37

38}; Chinese Acute Pancreatitis Clinical Trials Group (CAPCTG)

Collaborators, Affiliations

Collaborators

Chinese Acute Pancreatitis Clinical Trials Group (CAPCTG):
Wenjian Mao, Jiajia Lin, Mingfeng Huang, Mengjie Lu, Yan Chen, Baiqiang Li, Tao Chen, Fang Shao, Nonghua Lv, Yin Zhu, Liang Xia, Wenhua He, Zhenping Chen, Xinting Pan, Qingyun Zhu, Youdong Wan, Hong Mei, Kang Li, Miao Chen, Chengjian He, Hongyi Yao, Zigui Zhu, Weili Gu, Weihua Lu, Jingyi Wu, Feng Zhou, Shumin Tu, Long Fu, Bing Xue, Xiaofei Huang, Dandan Zhou, Lening Ren, Dahuan Li, Xiangyang Zhao, Wei Zhao, Xiaomei Chen, Junli Sun, Keke Xin, Weiwei Chen, Qingcheng Xu, Jingchun Song, Qingbo Zeng, Min Shao, Dongsheng Zhao, Jianfeng Tu, Hongguo Yang, Bin Wu, Huaguang Ye, Mingzhi Chen, Mei Yang, Hong Gao, Qiang Li, Lijuan Zhao, Guobing Chen, Yafei Li, Honghai Xia, Dongliang Yang, Shusheng Zhou, Jiyan Lin, Songjing Shi, Weijie Yao, Shan Xu, Lei Yu, Yongjun Lin, Yun Zhou, Quanxing Feng, Zhiyong Liu

Affiliations

¹ Department of Critical Care Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
² National Institute of Healthcare Data Science, Nanjing University, Nanjing, China.
³ Department of Critical Care Medicine, Jinling Hospital, Nanjing Medical School University, Nanjing, China.
⁴ Department of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, Yinchuan, China.
⁵ Department of Emergency, GanZhou People's Hospital, Nanchang University, Nanchang, China.
⁶ Department of Gastroenterology, Dr. Balmis, General University Hospital-ISABIAL, Alicante, Spain.
⁷ Pancreato-Biliary Endoscopy and Endosonography Division, Clinical Research Centre, Pancreas Translational, and, San Raffaele Scientific Institute IRCCS, Vita Salute San Raffaele University , Milan, Italy.
⁸ Department of Anesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Würzburg, Würzburg, 97080, Germany.
⁹ Department of Gastroenterology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
¹⁰ Centre of Excellence for Pancreatitis, Institute of Integrated Traditional Chinese and Western Medicine, West China-Liverpool Biomedical Research Centre, West China Hospital, Sichuan University, Chengdu, China.
¹¹ Department of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
¹² Department of Critical Care Medicine, Jinjiang Hospital of Traditional Chinese Medicine, Jinjiang, China.
¹³ Department of Emergency Medicine, The First Affiliated Hospital of Xiamen University, Xiamen, China.
¹⁴ Department of Critical Care Medicine, Fujian Provincial Hospital, Fuzhou, China.
¹⁵ The First Department of Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
¹⁶ Department of Critical Care Medicine, Medical Centre of Anesthesiology and Pain, The First Affiliated Hospital of Nanchang University, Nanchang, China.
¹⁷ Department of Emergency Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
¹⁸ Department of Emergency Medicine, Jiangsu Provincial Hospital of Integrated Chinese and Western Medicine, Nanjing, China.
¹⁹ The Fourth Department of the Digestive Disease Centre, Suining Central Hospital, Suining, China.
²⁰ Department of Critical Care Medicine, Qian Xi Nan People's Hospital, Zunyi Medical University, Zunyi, China.
²¹ Department of Intensive Care Unit, Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Hangzhou, China.
²² Department of Critical Care Medicine, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
²³ Department of Critical Care Medicine, Nanyang Central Hospital, Nanyang, China.
²⁴ Department of Emergency Medicine, The First Affiliated Hospital and College of Clinical Medicineof , Henan University of Science and Technology, Luoyang, China.
²⁵ Department of ICU, The Affiliated Huaian No. 1, People's Hospital of Nanjing Medical University, Huaian, China.
²⁶ Department of Emergency, Medical Centre Hospital of Qionglai City, Chengdu, China.
²⁷ Department of Critical Care Medicine, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.
²⁸ Department of Critical Care Medicine, The First Hospital of HanDan, Handan, China.
²⁹ Department of Critical Care Medicine, Bishan Hospital of Chongqing Medical University, Chongqing, China.
³⁰ Department of Critical Care Medicine, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
³¹ Department of Epidemiology and Health Statistics, School of Public Health, Jiaotong University Health Science Centre, Xi'an, China.
³² Surgical and Translational Research Centre, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
³³ Department of Biostatistics, School of Public Health, Southern Medical University, Guangzhou, China.
³⁴ Department of Critical Care Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing, China. ctgchina@medbit.cn.
³⁵ National Institute of Healthcare Data Science, Nanjing University, Nanjing, China. ctgchina@medbit.cn.
³⁶ Department of Critical Care Medicine, Jinling Hospital, Nanjing Medical School University, Nanjing, China. ctgchina@medbit.cn.
³⁷ Department of Critical Care Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing, China. ctgkelu@nju.edu.cn.
³⁸ National Institute of Healthcare Data Science, Nanjing University, Nanjing, China. ctgkelu@nju.edu.cn.

^# Contributed equally.

PMID: 39548430
PMCID: PMC11566486
DOI: 10.1186/s12916-024-03755-8

Multicenter Study

Triglyceride-lowering therapies in hypertriglyceridemia-associated acute pancreatitis in China: a multicentre prospective cohort study

Jing Zhou et al. BMC Med. 2024.

. 2024 Nov 15;22(1):535.

doi: 10.1186/s12916-024-03755-8.

Authors

Collaborators

Chinese Acute Pancreatitis Clinical Trials Group (CAPCTG):
Wenjian Mao, Jiajia Lin, Mingfeng Huang, Mengjie Lu, Yan Chen, Baiqiang Li, Tao Chen, Fang Shao, Nonghua Lv, Yin Zhu, Liang Xia, Wenhua He, Zhenping Chen, Xinting Pan, Qingyun Zhu, Youdong Wan, Hong Mei, Kang Li, Miao Chen, Chengjian He, Hongyi Yao, Zigui Zhu, Weili Gu, Weihua Lu, Jingyi Wu, Feng Zhou, Shumin Tu, Long Fu, Bing Xue, Xiaofei Huang, Dandan Zhou, Lening Ren, Dahuan Li, Xiangyang Zhao, Wei Zhao, Xiaomei Chen, Junli Sun, Keke Xin, Weiwei Chen, Qingcheng Xu, Jingchun Song, Qingbo Zeng, Min Shao, Dongsheng Zhao, Jianfeng Tu, Hongguo Yang, Bin Wu, Huaguang Ye, Mingzhi Chen, Mei Yang, Hong Gao, Qiang Li, Lijuan Zhao, Guobing Chen, Yafei Li, Honghai Xia, Dongliang Yang, Shusheng Zhou, Jiyan Lin, Songjing Shi, Weijie Yao, Shan Xu, Lei Yu, Yongjun Lin, Yun Zhou, Quanxing Feng, Zhiyong Liu

Affiliations

¹ Department of Critical Care Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
² National Institute of Healthcare Data Science, Nanjing University, Nanjing, China.
³ Department of Critical Care Medicine, Jinling Hospital, Nanjing Medical School University, Nanjing, China.
⁴ Department of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, Yinchuan, China.
⁵ Department of Emergency, GanZhou People's Hospital, Nanchang University, Nanchang, China.
⁶ Department of Gastroenterology, Dr. Balmis, General University Hospital-ISABIAL, Alicante, Spain.
⁷ Pancreato-Biliary Endoscopy and Endosonography Division, Clinical Research Centre, Pancreas Translational, and, San Raffaele Scientific Institute IRCCS, Vita Salute San Raffaele University , Milan, Italy.
⁸ Department of Anesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Würzburg, Würzburg, 97080, Germany.
⁹ Department of Gastroenterology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
¹⁰ Centre of Excellence for Pancreatitis, Institute of Integrated Traditional Chinese and Western Medicine, West China-Liverpool Biomedical Research Centre, West China Hospital, Sichuan University, Chengdu, China.
¹¹ Department of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
¹² Department of Critical Care Medicine, Jinjiang Hospital of Traditional Chinese Medicine, Jinjiang, China.
¹³ Department of Emergency Medicine, The First Affiliated Hospital of Xiamen University, Xiamen, China.
¹⁴ Department of Critical Care Medicine, Fujian Provincial Hospital, Fuzhou, China.
¹⁵ The First Department of Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
¹⁶ Department of Critical Care Medicine, Medical Centre of Anesthesiology and Pain, The First Affiliated Hospital of Nanchang University, Nanchang, China.
¹⁷ Department of Emergency Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
¹⁸ Department of Emergency Medicine, Jiangsu Provincial Hospital of Integrated Chinese and Western Medicine, Nanjing, China.
¹⁹ The Fourth Department of the Digestive Disease Centre, Suining Central Hospital, Suining, China.
²⁰ Department of Critical Care Medicine, Qian Xi Nan People's Hospital, Zunyi Medical University, Zunyi, China.
²¹ Department of Intensive Care Unit, Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Hangzhou, China.
²² Department of Critical Care Medicine, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
²³ Department of Critical Care Medicine, Nanyang Central Hospital, Nanyang, China.
²⁴ Department of Emergency Medicine, The First Affiliated Hospital and College of Clinical Medicineof , Henan University of Science and Technology, Luoyang, China.
²⁵ Department of ICU, The Affiliated Huaian No. 1, People's Hospital of Nanjing Medical University, Huaian, China.
²⁶ Department of Emergency, Medical Centre Hospital of Qionglai City, Chengdu, China.
²⁷ Department of Critical Care Medicine, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.
²⁸ Department of Critical Care Medicine, The First Hospital of HanDan, Handan, China.
²⁹ Department of Critical Care Medicine, Bishan Hospital of Chongqing Medical University, Chongqing, China.
³⁰ Department of Critical Care Medicine, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
³¹ Department of Epidemiology and Health Statistics, School of Public Health, Jiaotong University Health Science Centre, Xi'an, China.
³² Surgical and Translational Research Centre, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
³³ Department of Biostatistics, School of Public Health, Southern Medical University, Guangzhou, China.
³⁴ Department of Critical Care Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing, China. ctgchina@medbit.cn.
³⁵ National Institute of Healthcare Data Science, Nanjing University, Nanjing, China. ctgchina@medbit.cn.
³⁶ Department of Critical Care Medicine, Jinling Hospital, Nanjing Medical School University, Nanjing, China. ctgchina@medbit.cn.
³⁷ Department of Critical Care Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing, China. ctgkelu@nju.edu.cn.
³⁸ National Institute of Healthcare Data Science, Nanjing University, Nanjing, China. ctgkelu@nju.edu.cn.

^# Contributed equally.

PMID: 39548430
PMCID: PMC11566486
DOI: 10.1186/s12916-024-03755-8

Abstract

Background: No specific triglyceride-lowering therapy is recommended in patients with hypertriglyceridemia-associated acute pancreatitis (HTG-AP), primarily because of the lack of quality evidence. This study aimed to describe practice variations in triglyceride-lowering therapies for early HTG-AP patients and assess whether more rapid triglyceride decline is associated with improving organ failure.

Methods: This is a multicentre, prospective cohort study recruiting HTG-AP patients with elevated plasma triglyceride (> 11.3 mmol/L) admitted within 72 h from the onset of symptoms. Patients were dichotomised on study day 3 into either target reaching (plasma triglyceride ≤ 5.65 mmol/L) or not. The primary outcome was organ failure-free days (OFFD) to 14 days of enrolment. The association between target-reaching and OFFD was modelled. Additionally, the slope in plasma triglyceride over the first three days in response to treatment was calculated, and its association with OFFD was assessed as a sensitivity analysis.

Results: Among the 300 enrolled patients, 211 underwent exclusive medical treatment, and 89 underwent various blood purification therapies. Triglyceride levels were available in 230 patients on study day 3, among whom 122 (53.0%) had triglyceride levels of ≤ 5.65 mmol/l. The OFFD was not different between these patients and those in whom plasma triglyceride remained > 5.65 mmol/L [median (IQR): 13 (10-14) vs. 14 (10-14), p = 0.46], even after adjustment for potential confounders. For the decline slopes, there was no significant change in OFFD with a steeper decline slope [risk difference, - 0.088, 95% CI, - 0.334 to 0.158, p = 0.48].

Conclusions: Triglyceride-lowering therapies vary greatly across centres. More rapid triglyceride decline was not associated with improving incidence and duration of organ failure.

Keywords: Acute pancreatitis; Blood purification; Hypertriglyceridemia; Organ failure; Triglyceride.

PubMed Disclaimer

Conflict of interest statement

Declarations Ethics approval and consent to participate The study was approved by the ethics committee of Jinling Hospital (ethical number: 2020NZKY-016–01) and registered with the Chinese Clinical Trial Registry (ChiCTR2000039541). The local hospital ethics committees of all the participating sites also approved the trial. Consent for publication Not applicable. Competing interests The authors declare that they have no competing interests.

Figures

**Fig. 1**
Flow chart of patient enrolment. AP, acute pancreatitis; PE, plasma exchange; HF, haemofiltration; HP, haemoperfusion

**Fig. 2**
Distribution of treatment strategies over the first three days of enrolment. PE, plasma exchange; HP, haemoperfusion

**Fig. 3**
Organ failure resolution analysed using Fine-Gray competing risk analysis. OF, organ failure; TG, triglyceride; HR, hazard ratio

See this image and copyright information in PMC

References

1. Yadav D, Lowenfels AB. Trends in the epidemiology of the first attack of acute pancreatitis: a systematic review. Pancreas. 2006;33(4):323–30. - PubMed
1. Matta B, et al. Worldwide variations in demographics, management, and outcomes of acute pancreatitis. Clin Gastroenterol Hepatol. 2020;18(7):1567-1575 e2. - PMC - PubMed
1. Olesen SS, et al. Hypertriglyceridemia is often under recognized as an aetiologic risk factor for acute pancreatitis: a population-based cohort study. Pancreatology. 2021;21(2):334–41. - PubMed
1. Zhu Y, et al. A study on the etiology, severity, and mortality of 3260 patients with acute pancreatitis according to the revised Atlanta classification in Jiangxi, China over an 8-year period. Pancreas. 2017;46(4):504–9. - PubMed
1. He W, et al. Elevated hypertriglyceridemia and decreased gallstones in the etiological composition ratio of acute pancreatitis as affected by seasons and festivals: A Two-center real-world study from China. Front Cell Infect Microbiol. 2022;12: 976816. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- BioMed Central
- PubMed Central
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Triglyceride-lowering therapies in hypertriglyceridemia-associated acute pancreatitis in China: a multicentre prospective cohort study

Collaborators

Affiliations

Triglyceride-lowering therapies in hypertriglyceridemia-associated acute pancreatitis in China: a multicentre prospective cohort study

Authors

Collaborators

Affiliations

Abstract

Conflict of interest statement

Figures

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical